Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women.

Dittrich, Ralf; Kliesch, Sabine; Schüring, Andreas; Balcerek, Magdalena; Baston-Büst, Dunja M; Beck, Ramona; Beckmann, Matthias W; Behringer, Karolin; Borgmann-Staudt, Anja; Cremer, Wolfgang; Denzer, Christian; Diemer, Thorsten; Dorn, Almut; Fehm, Tanja; Gaase, Rüdiger; Germeyer, Ariane; Geue, Kristina; Ghadjar, Pirus; Goeckenjan, Maren; Götte, Martin; ... (2018). Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women. Geburtshilfe und Frauenheilkunde, 78(6), pp. 567-584. Thieme 10.1055/a-0611-5549

[img]
Preview
Text
29962516.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (264kB) | Preview

Aim The aim of this official guideline published by the German Society of Gynecology and Obstetrics (DGGG) and coordinated with the German Society of Urology (DGU) and the German Society of Reproductive Medicine (DGRM) is to provide consensus-based recommendations, obtained by evaluating the relevant literature, on counseling and fertility preservation for prepubertal girls and boys as well as patients of reproductive age. Statements and recommendations for girls and women are presented below. Statements or recommendations for boys and men are not the focus of this guideline. Methods This S2k guideline was developed at the suggestion of the guideline commission of the DGGG, DGU and DGRM and represents the structured consensus of representative members from various professional associations (n = 40). Recommendations The guideline provides recommendations on counseling and fertility preservation for women and girls which take account of the patient's personal circumstances, the planned oncologic therapy and the individual risk profile as well as the preferred approach for selected tumor entities.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology

UniBE Contributor:

von Wolff, Michael

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0016-5751

Publisher:

Thieme

Language:

German

Submitter:

Monika Zehr

Date Deposited:

27 Mar 2019 16:02

Last Modified:

27 Oct 2019 00:55

Publisher DOI:

10.1055/a-0611-5549

PubMed ID:

29962516

Uncontrolled Keywords:

fertility preservation guideline oncologic diseases

BORIS DOI:

10.7892/boris.126024

URI:

https://boris.unibe.ch/id/eprint/126024

Actions (login required)

Edit item Edit item
Provide Feedback